BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 956853)

  • 1. Rat brain beta-galactosidases: observations on cerebroside-beta-galactosidase catalysed transgalactosylation and comparison of assay methods for sphingolipid hydrolysis.
    Carter TP; Kanfer JN
    J Neurochem; 1976 Jul; 27(1):53-62. PubMed ID: 956853
    [No Abstract]   [Full Text] [Related]  

  • 2. Enzymatic hydrolysis of sphingolipids. V. Hydrolysis of monosialoganglioside and hexosylceramides by rat brain beta-galactosidase.
    Gatt S
    Biochim Biophys Acta; 1967 Feb; 137(1):192-5. PubMed ID: 6030372
    [No Abstract]   [Full Text] [Related]  

  • 3. The inhibitor-sensitive sites of galactosyl ceramide galactosidase.
    Arora RC; Lin YN; Radin NS
    Arch Biochem Biophys; 1973 May; 156(1):77-83. PubMed ID: 4738302
    [No Abstract]   [Full Text] [Related]  

  • 4. Glycosphingolipid beta-galactosidases. I. Standard assay procedures and characterization by electrofocusing and gel filtration of the enzymes in normal human liver.
    Suzuki Y; Suzuki K
    J Biol Chem; 1974 Apr; 249(7):2098-104. PubMed ID: 4856435
    [No Abstract]   [Full Text] [Related]  

  • 5. Glycosphingolipid beta-galactosidases. 3. Canine form of globoid cell leukodystrophy; comparison with the human disease.
    Suzuki Y; Miyatake T; Fletcher TF; Suzuki K
    J Biol Chem; 1974 Apr; 249(7):2109-12. PubMed ID: 4818826
    [No Abstract]   [Full Text] [Related]  

  • 6. Glycosphingolipid beta-galactosidases in rat brain: properties and the standard assay procedures of the enzymes in whole homogenate.
    Miyatake T; Suzuki K
    Biochim Biophys Acta; 1974 Mar; 337(3):333-42. PubMed ID: 4832624
    [No Abstract]   [Full Text] [Related]  

  • 7. Cerebroside galactosidase of brain.
    Hajra AK; Bowen DM; Kishimoto Y; Radin NS
    J Lipid Res; 1966 May; 7(3):379-86. PubMed ID: 5929353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingolipid beta-D-galactosidases in globoid cell leukodystrophy (Krabbe disease).
    Awasthi YC; Lund HW; Lo JT; Srivastava SK
    Birth Defects Orig Artic Ser; 1978; 14(6B):113-26. PubMed ID: 103589
    [No Abstract]   [Full Text] [Related]  

  • 9. Glial and neuronal localization of cerebroside-metabolizing enzymes.
    Radin NS; Brenkert A; Arora RC; Sellinger OZ; Flangas AL
    Brain Res; 1972 Apr; 39(1):163-9. PubMed ID: 5025640
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of myoinositol on galactosidase activities for sphingolipids.
    Takenawa T; Narumi K; Tsumita T
    Jpn J Exp Med; 1973 Aug; 43(4):331-9. PubMed ID: 4542324
    [No Abstract]   [Full Text] [Related]  

  • 11. Human brain cerebroside beta-galactosidase: deficiency of transgalactosidic activity in Krabbe's disease.
    Carter TP; Beblowski DW; Savage MH; Kanfer JN
    J Neurochem; 1980 Jan; 34(1):189-96. PubMed ID: 6778958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial purification and characterization of beta-galactosidase from rat brain hydrolyzing glycosphingolipids.
    Miyatake T; Suzuki K
    J Biol Chem; 1975 Jan; 250(2):585-92. PubMed ID: 1112780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of cerebroside galactosidase from rat brain.
    Bowen DM; Radin NS
    Biochim Biophys Acta; 1968 May; 152(3):587-98. PubMed ID: 5656826
    [No Abstract]   [Full Text] [Related]  

  • 14. The galactosyl moiety of brain cerebrosides.
    Radin NS
    Chem Phys Lipids; 1970 Oct; 5(1):178-92. PubMed ID: 5476321
    [No Abstract]   [Full Text] [Related]  

  • 15. Glycosphingolipid beta-galactosidases. IV. Electrofocusing characterization in G-M-1-gangliosides.
    Suzuki Y; Suzuki K
    J Biol Chem; 1974 Apr; 249(7):2113-7. PubMed ID: 4818827
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on galactosyl ceramide and lactosyl ceramide beta-galactosidase.
    Wenger DA
    Chem Phys Lipids; 1974 Dec; 13(4):327-9. PubMed ID: 4452215
    [No Abstract]   [Full Text] [Related]  

  • 17. Conversion by rat brain preparation of lignoceric acid to ceramides and cerebrosides containing both alpha-hydroxy and nonhydroxy fatty acids. Effects of compounds which affect sphingolipid metabolism.
    Singh I; Kishimoto Y; Vunnam RR; Radin NS
    J Biol Chem; 1979 May; 254(10):3840-4. PubMed ID: 438163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosphingolipid beta-galactosidases. II. Electrofocusing characterization of the enzymes in human globoid cell leukodystrophy (Krabbe's disease).
    Suzuki Y; Suzuki K
    J Biol Chem; 1974 Apr; 249(7):2105-8. PubMed ID: 4818825
    [No Abstract]   [Full Text] [Related]  

  • 19. Ceramide-like synthetic amides that inhibit cerebroside galactosidase.
    Arora RC; Radin NS
    J Lipid Res; 1972 Jan; 13(1):86-91. PubMed ID: 5059204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosyltransferases of rat brain that make cerebrosides: substrate specificity, inhibitors, and abnormal products.
    Warren KR; Misra RS; Arora RC; Radin NS
    J Neurochem; 1976 Jun; 26(6):1063-72. PubMed ID: 932714
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.